A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression
Open accessAbstract
Genome-wide association studies (GWASs) implicate the PHACTR1 locus (6p24) in risk for five vascular diseases, including coronary artery disease, migraine headache, cervical artery dissection, fibromuscular dysplasia, and hypertension. Through genetic fine mapping, we prioritized rs9349379, a common SNP in the third intron of the PHACTR1 gene, as the putative causal variant. Epigenomic data from human tissue revealed an enhancer signature at rs9349379 exclusively in aorta, suggesting a regulatory function for this SNP in the vasculature. CRISPR-edited stem cell-derived endothelial cells demonstrate rs9349379 regulates expression of endothelin 1 (EDN1), a gene located 600 kb upstream of PHACTR1. The known physiologic effects of EDN1 on the vasculature may explain the pattern of risk for the five associated diseases. Overall, these data illustrate the integration of genetic, phenotypic, and epigenetic analysis to identify the biologic mechanism by which a common, non-coding variant can distally regulate a gene and contribute to the pathogenesis of multiple vascular diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 14 cited sources checked · 0 supported · 0 flagged
- Findingown data
EDN1 expression was 50-fold higher in ECs than in VSMCs.
“Though EDN1 expression was differentially regulated in both ECs and VSMCs, there was a 50-fold higher expression in ECs (Figure S3C).”
Quote in the paperNot a substantial claim - Findingown data
WT and Δ88 iPSCs differentiated into neural crest progenitor cells showed no differential gene expression.
“There was no differential gene expression between wild-type (WT) and Δ88 iPSCs differentiated to a non-vascular cell type, neural crest progenitor cells (Figure S3B).”
Quote in the paperSubstantial claim - Findingown data
Human tissue epigenomic data showed an enhancer mark at rs9349379 only in aorta.
“Epigenomic data from human tissue revealed an enhancer signature at rs9349379 exclusively in aorta, suggesting a regulatory function for this SNP in the vasculature.”
- Also stated in: § A Vascular-Specific Regulatory Region at rs9349379 · plain
“In these aortic samples, a strong enhancer signal overlies rs9349379 (Figure 2B), spanning 1 kb.”
Quote in the paperSubstantial claim - Also stated in: § A Vascular-Specific Regulatory Region at rs9349379 · plain
- Findingown data
In the UK Biobank PheWAS, rs9349379 showed no significant association with any other diseases.
“There was no significant association of rs9349379 with any other diseases in the UK Biobank PheWAS (Figure S1C).”
Quote in the paperSubstantial claim - Findingown data
Gene set enrichment analysis showed strong enrichment for blood vessel development (FDR=1.64e-10), vasculature development (FDR=2.98e-10), and blood vessel morphogenesis (FDR=2.21e-9).
“Gene set enrichment analysis of the differentially expressed genes showed strong enrichment for blood vessel development (FDR = 1.64 × 10−10), vasculature development (FDR = 2.98 × 10−10), and blood vessel morphogenesis (FDR = 2.21 × 10−9).”
Quote in the paperNot a substantial claim
- Findingown data
No H3K27Ac signal was detected at the 6p24 locus in the ENCODE phase 1 and 2 datasets.
“However, there was no detectable H3K27Ac signal at this locus in these datasets (Figure 2A).”
Quote in the paperSubstantial claim - Findingown data
Five other genes within 1 Mb of rs9349379, including PHACTR1, showed no significant expression difference in either cell type.
“Expression of five other genes in the 1-Mb region surrounding rs9349379, including PHACTR1, did not differ significantly for either cell type.”
Quote in the paperSubstantial claim - Findingown data
CRISPR-edited stem cell-derived endothelial cells show that rs9349379 controls EDN1 expression.
“CRISPR-edited stem cell-derived endothelial cells demonstrate rs9349379 regulates expression of endothelin 1 (EDN1), a gene located 600 kb upstream of PHACTR1.”
- Also stated in: § Targeted Deletion at the 6p24 Regulatory Element Increases EDN1 Expression in Vascular Cells · plain
“In both iPSC-derived ECs and VSMCs, loss of the 88 bp flanking rs9349379 resulted in higher expression of the endothelin-1 (EDN1) gene compared with wild-type lines (Figure 3B).”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Also stated in: § Targeted Deletion at the 6p24 Regulatory Element Increases EDN1 Expression in Vascular Cells · plain
- Findingown data
The gene set enrichment results from Δ88 cells overlapped significantly with those from A/A versus G/G ESC-ECs.
“There was significant overlap in the gene set enrichment analysis represented by these differentially regulated genes and those from RNA-seq of the A/A and G/G ESC-ECs.”
Quote in the paperSubstantial claim - Findingown data
The UK Biobank PheWAS reproduced prior associations for CAD and migraine headache (CAD p=1.16e-11; migraine p=0.000717).
“The UK Biobank PheWAS confirmed the previously published associations for CAD and migraine headache (Figure 1B; CAD p = 1.16 × 10−11; migraine p = 0.000717).”
Quote in the paperSubstantial claim - Findingown data
After adjustment for rs9349379, no second independent CAD/MI signal remained at 6p24.
“This conditional analysis, after adjusting for rs9349379, showed no evidence of a second independent CAD/myocardial infarction (MI) association at this locus (Figure S1).”
Quote in the paperSubstantial claim - Findingown data
EDN1, located over 600 kb away, was the only differentially regulated gene within 2 Mb of rs9349379.
“EDN1, a gene over 600 kb distal to rs9349379, was the only differentially regulated gene within 2 Mb of rs9349379 (Figure 4C).”
Quote in the paperSubstantial claim - Findingown data
RNA-seq in six WT and six Δ88 cells identified 423 differentially regulated genes.
“RNA-seq was also conducted in six WT and six Δ88 cells, and, of the 173,259 analyzed transcripts, there were 423 differentially regulated genes (Figure S4F).”
Quote in the paperNot a substantial claim - Findingown data
In aortic samples, a strong enhancer signal spanning 1 kb overlapped rs9349379.
“In these aortic samples, a strong enhancer signal overlies rs9349379 (Figure 2B), spanning 1 kb.”
Quote in the paperSubstantial claim - Findingcitation
The PICS algorithm assigned rs9349379 a greater than 99% probability of being the causal SNP given the local haplotype structure.
“The Probabilistic Identification of Causal SNPs (PICS) algorithm (Farh et al., 2015) also identifies rs9349379 as the causal SNP, given the haplotype structure at the locus, with greater than 99% probability (Table S1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Farh et al., 2015 source
Not checked in the free run.
- Findingown data
Differentially regulated genes included vascular wall mediators such as COL4A1, COL3A1, and FN1.
“The differentially regulated genes included several mediators of vascular wall integrity and structure, such as COL4A1, COL3A1, and FN1 (Figure S4E), which may be downstream effects of increased EDN1 expression in the G/G ESC-ECs (Amiri et al., 2004; Shi-Wen et al., 2001).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Findingown data
In iPSC-derived ECs and VSMCs, deleting the 88 bp around rs9349379 raised EDN1 expression relative to wild-type cells.
“In both iPSC-derived ECs and VSMCs, loss of the 88 bp flanking rs9349379 resulted in higher expression of the endothelin-1 (EDN1) gene compared with wild-type lines (Figure 3B).”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Findingown data
All four aortic samples showed robust H3K27 acetylation at rs9349379.
“All four demonstrate robust H3K27 acetylation at rs9349379 (Figure S2).”
Quote in the paperSubstantial claim - Findingown data
Genetic fine mapping singled out rs9349379 as the likely causal variant at 6p24.
“Through genetic fine mapping, we prioritized rs9349379, a common SNP in the third intron of the PHACTR1 gene, as the putative causal variant.”
- Also stated in: § Fine Mapping Prioritizes a Causal Variant at 6p24 · plain
“The strongest association was for a single variant, rs9349379, with an association of 1.81 × 10−42 (odds ratio [OR] = 1.14), far exceeding the association signal for the next most highly associated SNP, rs78145402 (OR = 1.08, 4.69 × 10−17).”
Quote in the paperSubstantial claim - Also stated in: § Fine Mapping Prioritizes a Causal Variant at 6p24 · plain
- Findingown data
Among 38,817 European-ancestry UK Biobank participants, the rs9349379 G allele was linked to lower arterial stiffness index (β=-0.077; 95% CI -0.034 to -0.119; p=0.0004).
“In 38,817 participants of European ancestry, the G allele at rs9349379 was associated with decreased arterial stiffness index, with β = −0.077 (95% confidence interval [CI]: −0.034, −0.119), p = 0.0004.”
Quote in the paperSubstantial claim - Findingown data
IL-1α stimulation increased EDN1 expression in both WT and Δ88 ECs at mRNA (p=0.005) and protein (p=0.0004) levels.
“Stimulation with IL-1α increased EDN1 expression both in WT and D88 ECs at the mRNA (Figure 3D; p = 0.005) and protein levels (Figure 3E; p = 0.0004).”
Quote in the paperNot a substantial claim - Findingown data
A possible overlapping contact area was found intergenic to EDN1 and PHACTR1.
“There was a possible area of overlap intergenic to EDN1 and PHACTR1 (Figure 5A).”
Quote in the paperNot a substantial claim - Findingown data
The study demonstrates regulation of a gene located 600 kb from the causal variant.
“Here we demonstrate the regulation of a gene 600 kb from the causal variant.”
Quote in the paperSubstantial claim - Findingown data
In this study, the causal variant's cis-regulatory effect was a 20% increase in EDN1 expression in genome-edited ECs homozygous for the G allele.
“In this study, the cis-regulatory effect of the causal variant is a 20% increase in EDN1 expression in the genome-edited ECs homozygous for the G allele.”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Findingown data
This common contact site contains a series of strong enhancers, as shown by H3K27Ac signal.
“This common contact site also contains a series of strong enhancers, as demonstrated by H3K27Ac signal.”
Quote in the paperNot a substantial claim- Rests on an assumption: The common contact site about 300 kb from both EDN1 and rs9349379 is the route by which the distal regulatory effect on EDN1 occurs.
- Findingown data
In 99 healthy plasma samples, the rs9349379 G genotype was significantly associated with higher Big ET-1 levels under an additive model (p=0.00136).
“We found a significant association between G genotype at rs9349379 and higher Big ET-1 levels using an additive model of regression (Figure 6; p = 0.00136).”
Quote in the paperSubstantial claim - Findingown data
4C-seq from the rs9349379 site showed a smaller contact region spanning chr6:12,690,000-13,350,000.
“4C-seq from the rs9349379 site demonstrated a smaller contact region that extended from chr6:12,690,000–13,350,000.”
Quote in the paperNot a substantial claim - Findingown data
The data point to a common contact site about 300 kb from both the EDN1 promoter and the rs9349379 regulatory element.
“Instead, the data point to a common contact site approximately 300 kb from both the EDN1 promoter and rs9349379 regulatory element.”
Quote in the paperSubstantial claim- Rests on an assumption: The common contact site about 300 kb from both EDN1 and rs9349379 is the route by which the distal regulatory effect on EDN1 occurs.
- Findingown data
This region had high H3K27Ac signal in ECs, consistent with a super enhancer.
“Notably, this region featured high levels of H3K27Ac signal in ECs, consistent with a super enhancer (Figure 5B).”
Quote in the paperNot a substantial claim - Findingown data
Homozygous minor ESC-ECs produced more ET-1 protein in supernatants at 24 hr with or without IL-1α (unstimulated p=2.12e-5; IL-1α stimulated p=0.0006).
“The homozygous minor ESC-ECs also produced more ET-1 protein in the cell-free supernatants at 24 hr in the presence or absence of IL-1α stimulation (Figure 4E; unstimulated p = 2.12 × 10−5 and IL-1α stimulated p = 0.0006).”
Quote in the paperSubstantial claim - Findingown data
The EDN1 promoter contacts multiple sites up to 500 kb away in both the 3′ and 5′ directions.
“The EDN1 promoter contacts multiple sites extending up to 500 kb in both the 3′ and 5′ directions.”
Quote in the paperNot a substantial claim - Findingown data
The common contact region contains four distinct H3K27Ac peaks.
“The common contact region contains four distinct peaks of H3K27Ac signal.”
Quote in the paperNot a substantial claim - Findingown data
The same chromatin structure appeared in 4C-seq from aortic ECs, iPSC-derived ECs, aortic VSMCs, and primary human monocytes.
“The same chromatin structure was seen in 4C-seq from aortic ECs, iPSC-derived ECs, aortic VSMCs, and primary human monocytes (Figure S5).”
Quote in the paperSubstantial claim - Interpretationown data
Statistical evidence makes rs9349379 the probable causal SNP for the multiple vascular disease associations at 6p24.
“Thus, statistical evidence prioritizes rs9349379 as a likely causal SNP for the multiple vascular disease associations at this locus.”
Quote in the paperSubstantial claim - Interpretationown data
Together, the genetic results point to a role for rs9349379 in human endothelial cell function.
“In aggregate, these genetic data suggest a role for rs9349379 in human endothelial cell function, and our subsequent experiments prioritized the use of endothelial cells to characterize underlying mechanisms.”
Quote in the paperSubstantial claim - Interpretationown data
The aortic epigenomic data suggest that a gene regulatory function operates at this locus in vascular tissue.
“These data suggest a gene regulatory function exists at this locus in vascular tissue.”
Quote in the paperSubstantial claim - Interpretationreasoning
The known vascular actions of EDN1 can account for the risk pattern seen across the five associated diseases.
“The known physiologic effects of EDN1 on the vasculature may explain the pattern of risk for the five associated diseases.”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Rests on an assumption: A roughly 20% change in EDN1 expression caused by rs9349379 is large enough to influence risk of the five vascular diseases.
- Interpretationown data
Deleting the small regulatory region at rs9349379 increases EDN1 expression and ET-1 protein production in ECs and, less strongly, in VSMCs.
“These data demonstrate that deletion of a small region of apparent regulatory DNA at rs9349379 results in increased EDN1 expression and endothelin-1 (ET-1) protein production in ECs and to a lesser extent in VSMCs.”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Premisecitation
The PHACTR1 region at 6p24 is linked by genome-wide studies to five vascular conditions: high blood pressure, fibromuscular dysplasia, cervical artery dissection, migraine, and coronary heart disease.
“Genome-wide association studies (GWASs) implicate the PHACTR1 locus (6p24) in risk for five vascular diseases, including coronary artery disease, migraine headache, cervical artery dissection, fibro-muscular dysplasia, and hypertension.”
- Also stated in: § Introduction · plain
“Common DNA sequence variants at 6p24 have shown genome-wide significant association with early-onset myocardial infarction (Myocardial Infarction Genetics Consortium et al., 2009), CAD (CARDIoGRAMplusC4D Consortium et al., 2013; Nikpay et al., 2015), coronary artery calcification (O'Donnell et al., 2011), migraine headache (Anttila et al., 2013), cervical artery dissection (Debette et al., 2015),”
Quote in the paperSubstantial claim0 of 3 sources checked - Also stated in: § Introduction · plain
- Interpretationown data
The distal cis-regulatory effect at 6q24 does not appear to occur through canonical enhancer-promoter contact.
“The mechanism of the distal cis-regulatory effect at 6q24 does not appear to be through canonical enhancer-promoter contact.”
Quote in the paperSubstantial claim- Rests on an assumption: The common contact site about 300 kb from both EDN1 and rs9349379 is the route by which the distal regulatory effect on EDN1 occurs.
- Interpretationcitation
The authors' data indicate that greater endothelial ET-1 production and subsequent ETA receptor binding promote atherosclerosis.
“Our data indicate that increased endothelial production of ET-1 and subsequent binding to the ETA receptor promotes atherosclerosis.”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Rests on an assumption: A roughly 20% change in EDN1 expression caused by rs9349379 is large enough to influence risk of the five vascular diseases.
- Interpretationown data
The long-range chromatin loops suggest that rs9349379 regulates EDN1 without a traditional enhancer-promoter interaction.
“The significance of these long-range chromatin loops in the regulation of EDN1 merits further study, but they suggest that the regulatory effect of rs9349379 on EDN1 is not through traditional enhancer-promoter interactions.”
Quote in the paperSubstantial claim - Interpretationreasoning
The link between the G allele and lower systolic blood pressure may be explained by ET-1 acting through the ETB receptor.
“Finally, the association of the G allele with lower systolic blood pressure (Surendran et al., 2016) may be explained by the action of ET-1 on the second endothelin receptor, ETB.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Surendran et al., 2016 source
Not checked in the free run.
- Interpretationown data
In summary, several lines of evidence indicate that a common DNA variant linked to five vascular diseases regulates EDN1 more than 600 kb away.
“In summary, we provide several lines of evidence that a common DNA variant associated with five vascular diseases regulates a gene, EDN1, located over 600 kb upstream in genomic distance.”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Rests on an assumption: A roughly 20% change in EDN1 expression caused by rs9349379 is large enough to influence risk of the five vascular diseases.
- Classified as probably not a substantial claim. 19
- May combine two claims. 17
- The quote only partly states this claim. 3
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataTBC1D7 expression differed by qPCR (p=1.75e-5), but this was not seen in RNA-seq from separately differentiated cells or in Δ88 deletions.
“There was a significant difference in TBC1D7 expression by qPCR (p = 1.75 × 10−5); however, this was not seen in the RNA-seq quantification from separately differentiated cells or the Δ88 deletions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMost differentially expressed transcripts had log2 fold changes below 1.5 (243 of 279, 87%).
“The majority of these differentially expressed transcripts had log2 fold changes <1.5 (243/279,87%; Figure S4D).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe rs9349379 G allele, at 36% frequency, raises risk for CAD and coronary calcification but lowers risk for migraine, cervical artery dissection, fibromuscular dysplasia, and hypertension.
“The pattern of association is striking as the minor allele at rs9349379 (G, 36% frequency) leads to increased risk for CAD and coronary calcification but decreased risk for four conditions (migraine headache, cervical artery dissection, fibromuscular dysplasia, and hypertension).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataESC-derived ECs reproduced the regulatory effect, with Δ88 ESC-ECs showing higher EDN1 expression than WT ESC-ECs (p=0.0004).
“ESC-derived ECs confirmed the regulatory effect, and Δ88 ESC-ECs demonstrated higher expression compared with WT ESC-ECs (Figure 3C; p = 0.0004).”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
May combine two claims.
Findingown dataAt 6p24, rs9349379 had the strongest association signal, with p=1.81e-42 and OR=1.14, stronger than the next SNP rs78145402 (OR=1.08, p=4.69e-17).
“The strongest association was for a single variant, rs9349379, with an association of 1.81 × 10−42 (odds ratio [OR] = 1.14), far exceeding the association signal for the next most highly associated SNP, rs78145402 (OR = 1.08, 4.69 × 10−17).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn Δ88 RNA-seq, the top pathways were blood vessel development (FDR=2.6e-7) and blood vessel morphogenesis (FDR=2.6e-7).
“The top pathways were also blood vessel development (FDR = 2.6 × 10∼7) and blood vessel morphogenesis (FDR = 2.6 × 10−7).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataIn 16,662 participants, the rs9349379 G allele was associated with lower flow-mediated vasodilation (β=-0.1209; 95% CI -0.5535 to -0.6188; p=0.004).
“The G allele at rs9349379 was associated with decreased flow-mediated vasodilation (β = −0.1209 [95% CI: −0.5535, −0.6188], p = 0.004).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataRNA-seq comparing A/A and G/G ESC-ECs found 279 differentially expressed transcripts at FDR<0.05, with samples clustering by rs9349379 genotype.
“We found 279 differentially expressed (false discovery rate [FDR] < 0.05) transcripts, with clustering of samples according to rs9349379 genotype as expected (Figure 4B).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataqPCR confirmed the RNA-seq expression differences and showed a cis-regulatory effect of rs9349379 genotype on EDN1, with the minor allele increasing EDN1 (p=7.59e-7).
“The qPCR confirmed the differential gene expression seen by RNA-seq, and it demonstrated a cis-regulatory effect of genotype at rs9349379 on EDN1 expression, with the minor allele driving increased EDN1 expression (Figure 4D; p = 7.59 × 10−7).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datars9349379 was associated with systolic blood pressure but not with lipids, weight, diabetes, or other related measures.
“Analysis for association between rs9349379 and cardiovascular risk factors confirmed the previously reported association with systolic blood pressure, but no relationship with lipid concentrations, weight, diabetes, or other related measures (Figure S1B, data obtained from analysis of multiple studies listed in Table S3).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataSex had no significant effect on ET-1 expression (p=0.26).
“There was no significant effect of sex on ET-1 expression (Figure S6; p = 0.26).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data4C-seq showed very low contact probability and no focal loop between rs9349379 and the EDN1 promoter.
“4C-seq revealed a very low contact probability and no evidence for a focal loop between rs9349379 and the EDN1 promoter (Figure 5A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn VSMCs, EDN1 was the only differentially expressed transcript in the 6p24 locus (p=0.012), and its expression was 50-fold lower than in ECs.
“EDN1 was the only differentially expressed transcript in the 6p24 locus (Figure 4F; p = 0.012) in VSMCs; however, the level of EDN1 expression was 50-fold lower in VSMCs than in ECs.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationCOL4A1, COL3A1, and FN1 may be downstream consequences of higher EDN1 expression in G/G ESC-ECs.
“The differentially regulated genes included several mediators of vascular wall integrity and structure, such as COL4A1, COL3A1, and FN1 (Figure S4E), which may be downstream effects of increased EDN1 expression in the G/G ESC-ECs (Amiri et al., 2004; Shi-Wen et al., 2001).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Amiri et al., 2004
Not checked in the free run.
- cites Shi-Wen et al., 2001
Not checked in the free run.
May combine two claims.
Interpretationown dataIn both deletion and allelic-series EC RNA-seq, rs9349379 regulatory effects fell in vascular development pathways and may be explained by its cis effect on EDN1.
“In RNA-seq from both the deletion and allelic series ECs, the regulatory effects of rs9349379 localized to vascular development pathways, and they may be explained by the cis-regulatory effect on EDN1 expression.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAll luciferase reporter constructs were confirmed by Sanger sequencing of the plasmids.
“All constructs were verified by Sanger sequencing of plasmids.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPlasma BigET-1 levels were analyzed with an additive linear regression model that included sex and age as covariates.
“Human plasma BigET-1 levels were analyzed using additive model of linear regression with sex and age as co-variates.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenPlasma samples were restricted to individuals with a Charlson Comorbidity Score of 0 who were not using antihypertensive medications.
“Samples were limited to those with Charlson Comorbidity Scores of 0, and individuals not taking any antihypertensive medications.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataRNA sequencing was carried out on samples with an RNA integrity number of 10.
“RNA-sequencing was conducted on samples with RIN of 10 (Agilent Technologies).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe rs9349379 G allele is associated with lower risk of migraine, cervical artery dissection, and fibromuscular dysplasia, three conditions that co-occur epidemiologically.
“The G allele at rs9349379 is associated with decreased risk for migraine headache, cervical artery dissection, and fibromuscular dysplasia—three diseases that co-occur epidemiologically (Olin et al., 2014; Pezzini et al., 2005; Rubinstein et al., 2005).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Olin et al., 2014
Not checked in the free run.
- cites Pezzini et al., 2005
Not checked in the free run.
- cites Rubinstein et al., 2005
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductown dataIn the analysis of phenotypic associations, the study adjusted for age, sex, ten principal components of ancestry, and genotyping array type when testing rs9349379 against 36 diseases.
“Phenotypic associations were analyzed using logistic regression, adjusting for age, sex, ten principal components of ancestry and a dummy variable for the array type used in genotyping, was used to test for the presence of association between rs9349379 and each of the 36 different diseases.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Interpretationown dataThe plasma analysis adds human-sample support for an association between rs9349379 and the vasoactive ET-1 peptide.
“This analysis provides further support in human samples of the association between rs93493979 and the vasoactive ET-1 peptide.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataReal-time PCR experiments were performed on three independently differentiated cell clones, with three technical replicates per clone.
“All experiments used 3 separately differentiated cellular clones, and differentiation was conducted in parallel. Data represent the average of three technical replicates per clone, and statistical analysis on three independently differentiated clones (n = 3).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe genetic findings suggest that migraine, dissection, and fibromuscular dysplasia may share pathophysiology through one or more downstream ET-1 effects, though further investigation is needed.
“The genetic data suggest the shared pathophysiology of migraine, dissection, and fibromuscular dysplasia may occur through one or more of these downstream effects of ET-1, though this requires further investigation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe data fit a physiology in which the G allele raises EDN1 expression, increases ET-1 binding to ETA on VSMCs, causes vasoconstriction, and thereby lowers migraine risk.
“Our data are consistent with this physiology, as the G allele at rs9349379 results in higher EDN1 expression, increased ET-1 binding to the ETA receptor on VSMCs, vasoconstriction, and, therefore, reduced risk of migraine headache.”
Quote in the paperSubstantial claim- Rests on an assumption: The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
- Rests on an assumption: A roughly 20% change in EDN1 expression caused by rs9349379 is large enough to influence risk of the five vascular diseases.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductown dataGenomic deletions were checked by agarose gel electrophoresis and validated by Sanger sequencing.
“Genomic deletions were screened for with agarose gel electrophoresis of PCR amplicons and confirmed with Sanger sequencing of PCR amplicons.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductreasoningTo control for Cas9 off-target effects, three wild-type and three mutant clones for each intended mutation were expanded.
“To account for off-target effects of the Cas9 nuclease, 3 wild-type and 3 clones with each desired mutations were expanded.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. The quote only partly states this claim.
Study design and conductown dataRNA sequencing was performed on endothelial cells derived from three homozygous major and three homozygous minor stem cell lines.
“3 homozygous major (A/A) and 3 homozygous minor (G/G) stem cell lines were differentiated into ECs as described above.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductown dataThe study used a Bonferroni-corrected significance threshold of 0.0014, derived from 0.05 divided by 36.
“A Bonferroni-adjusted p value of 0.0014 (0.05/36) was used as the threshold for statistical significance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataConfirmatory qPCR for EDN1, PHACTR1, SIRT1, GFOD1, HIVEP1, and TBC1D7 used validated probes and HPRT1 as the reference gene.
“Confirmatory qPCR conducted on EDN1, PHACTR1, SIRT1, GFOD1, HIVEP1, and TBC1D7 was assessed using validated probes, with HPRT1 as a reference gene.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenEach ELISA experiment contained nine samples, comprising three independently differentiated clones each cultured in three wells.
“Each experiment included 9 samples (3 independently differentiated clones, cultured in 3 wells each).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThree homozygous major and three homozygous minor clones were selected for subsequent study.
“3 homozygous major and 3 homozygous minor clones were selected for further study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThirty-three plasma samples were selected for each genotype at rs9349379.
“33 samples of each genotype at rs9349379 were selected.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFor each cell line, three wild-type and three biallelic 88-base-pair deletion clones were chosen for further experiments.
“In each cell line, 3 wild-type and 3 biallelic 88 base pair deletions were selected for further study.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationPublicly available ChIP-seq datasets were used to corroborate the findings from iPSC-derived endothelial cells.
“Publicly available ChIP-seq data were used to confirm findings from iPSC-ECs. (HUVEC, H3K27Ac ChIP-seq: GEO Data GSE53998; (Brown et al., 2014) iPSC/Embryonic-EC, H3K27Ac ChIP-seq: (GNomEx, Accession number: 195R2; (Theodoris et al., 2015)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Brown et al., 2014
Not checked in the free run.
- cites Theodoris et al., 2015
Not checked in the free run.
The paper relies on this without support.
The genome-edited pluripotent stem cell-derived endothelial and smooth muscle cells faithfully model human vascular cell biology and the in vivo regulation of EDN1 by rs9349379.
“we performed genome-editing experiments inpluripotent stem cells, and we differentiated these cells into two vascular cell types: endothelial cells (ECs) and vascular smooth muscle cells (VSMCs).”
“In both iPSC-derived ECs and VSMCs, loss of the 88 bp flanking rs9349379 resulted in higher expression of the endothelin-1 (EDN1) gene compared with wild-type lines (Figure 3B).”
The paper relies on this without support.
A roughly 20% change in EDN1 expression caused by rs9349379 is large enough to influence risk of the five vascular diseases.
“In this study, the cis-regulatory effect of the causal variant is a 20% increase in EDN1 expression in the genome-edited ECs homozygous for the G allele.”
“In summary, we provide several lines of evidence that a common DNA variant associated with five vascular diseases regulates a gene, EDN1, located over 600 kb upstream in genomic distance.”
The paper relies on this without support.
The common contact site about 300 kb from both EDN1 and rs9349379 is the route by which the distal regulatory effect on EDN1 occurs.
“Instead, the data point to a common contact site approximately 300 kb from both the EDN1 promoter and rs9349379 regulatory element.”
“The EDN1 locus may represent another example of such distal regulation, but further work is necessary to establish the mechanism by which the common contact site mediates gene expression.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Similar functional descriptions have been reported for individual loci implicated in schizophrenia, cardiovascular disease, type 2 diabetes and Alzheimer's disease.
“Similar functional descriptions have been reported for individual loci implicated in schizo phrenia64, cardiovascular disease104, type 2 diabetes105 and Alzheimer’s disease106, among others.”
From A brief history of human disease genetics (2020) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Flow-mediated dilation estimate falls outside its confidence interval
MajorThe reported effect estimate of −0.1209 is outside the stated 95% confidence interval, whose endpoints are both below −0.55. The interval's endpoints are also printed in descending order.
“β = −0.1209”
“[95% CI: −0.5535, −0.6188]”
Plasma-sample eligibility uses two different comorbidity scores
MinorThe results and assay methods specify a Charlson score of 0, but the human-subjects methods define the no-other-diagnoses criterion using an index of 1.
“patients with a Charlson Comorbidity Score of 0 and no anti-hypertensive medication use were selected for analysis.”
“no other medical diagnoses (defined by Charlson comorbidity index of 1)”
Listed qPCR target does not match the listed probe
MinorThe methods list SIRT1 among the qPCR targets but identify the corresponding listed SIRT probe as SIRT5.
“Confirmatory qPCR conducted on EDN1, PHACTR1, SIRT1, GFOD1, HIVEP1, and TBC1D7”
“Hs00978335_m1 (SIRT5)”
Arterial-stiffness sample size differs between sections
MinorThe results give 38,817 participants, while the methods give 38,795 individuals for the arterial-stiffness analysis.
“In 38,817 participants of European ancestry, the G allele at rs9349379 was associated with decreased arterial stiffness index”
“In UK Biobank, 38,795 individuals of European ancestry with available genotype data and arterial stiffness index (ASI) measurement were analyzed.”
Human-plasma conclusion names a different SNP
MinorThe plasma analysis is described as testing rs9349379, but its concluding sentence names rs93493979.
“This analysis provides further support in human samples of the association between rs93493979 and the vasoactive ET-1 peptide.”
“A total of 99 plasma samples were obtained, with 33 samples of each genotype at rs9349379 (A/A, A/G, G/G).”
Discussion switches the locus to the other chromosome arm
MinorThe discussion calls the distal regulatory locus 6q24, whereas the paper otherwise identifies the studied locus as 6p24.
“The mechanism of the distal cis-regulatory effect at 6q24 does not appear to be through canonical enhancer-promoter contact.”
“The 6p24 locus is linked to five vascular diseases through common variant association studies.”
The citation lists haven’t been fetched yet
References 76 · Cited by 450
Research works printed but not linked: 3
- Corretti, 2002, Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force, J. Am. Coll. Cardiol., 39, 257, 10.1016/S0735-1097(01)01746-6 · DOI
- Olin, 2014, Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association, Circulation, 129, 1048, 10.1161/01.cir.0000442577.96802.8c · DOI
- Pollock, 2010, Dissecting the complex physiology of endothelin: new lessons from genetic models, Hypertension, 56, 31, 10.1161/HYPERTENSIONAHA.109.139758 · DOI
- Authors
- Gupta, R. M., Hadaya, J., Trehan, A., Zekavat, S. M., Roselli, C., Klarin, D., Emdin, C. A., Hilvering, C. R. E., Bianchi, V., Mueller, C., Khera, A. V., Ryan, R. J. H., Engreitz, J. M., Issner, R., Shoresh, N., Epstein, C. B., de Laat, W., Brown, J. D., Schnabel, R. B., Bernstein, B. E., & Kathiresan, S.
- Affiliations
- Broad Institute (US)
- University Medical Center Utrecht (NL)
- University Medical Center Hamburg-Eppendorf (DE)
- Vanderbilt University Medical Center (US)
- Corresponding author
- Gupta, Rajat M.
- Kathiresan, Sekar
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 170
- Issue
- 3
- Pages
- 522-533.e15
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC5785707
- OpenAlex
- W2739458618
- Cited by
- 450
- References
- 76
- Citations by year
- 2026: 23 · 2025: 35 · 2024: 50 · 2023: 44 · 2022: 56 · 2021: 50 · 2020: 63 · 2019: 61 · 2018: 54 · 2017: 12 · 2015: 1
- FWCI
- 34.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Funders
- Sarnoff Scholar Award
- Harvard Catalyst CMERIT Award
- NIH (NHLBI K08-HL128810, T32 HL007734)
- NIH NIDDK (R01 DK097768)
- Fondation Leducq CVGeneF(x) Transatlantic Network of Excellence (R01HL127564)
- Ofer and Shelly Nemirovsky MGH Research Scholar Award
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Neurology › Cerebrovascular and genetic disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Keywords
- PHACTR1, endothelin-1, coronary artery disease, migraine, cervical artery dissection, fibromuscular dysplasia, hypertension, vascular disease, enhancers, non-coding variants, aorta, stem cell-derived endothelial cells
- MeSH terms
- Gene Editing, Acetylation, Cells, Cultured, Chromatin, Chromosome Mapping, Chromosomes, Human, Pair 6, Coronary Artery Disease, Histones, Humans, Muscle, Smooth, Vascular, Vascular Diseases, Gene Expression, Endothelin-1, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Endothelial Cells, Genome-Wide Association Study, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review